Cargando…

Prognostic role of genetic biomarkers in clinical progression of prostate cancer

The aim of this study was to analyze the use of 12 single-nucleotide polymorphisms in genes ELAC2, RNASEL and MSR1 as biomarkers for prostate cancer (PCa) detection and progression, as well as perform a genetic classification of high-risk patients. A cohort of 451 men (235 patients and 216 controls)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alvarez-Cubero, Maria Jesus, Martinez-Gonzalez, Luis Javier, Saiz, Maria, Carmona-Saez, Pedro, Alvarez, Juan Carlos, Pascual-Geler, Manrique, Lorente, Jose Antonio, Cozar, Jose Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558485/ https://www.ncbi.nlm.nih.gov/pubmed/26251261 http://dx.doi.org/10.1038/emm.2015.43

Ejemplares similares

Association between polymorphisms in sex hormones synthesis and metabolism and prostate cancer aggressiveness
por: Robles-Fernandez, Inmaculada, et al.
Publicado: (2017)

The potential impact of adding genetic markers to clinical parameters in managing high-risk prostate cancer patients
por: Alvarez-Cubero, Maria Jesus, et al.
Publicado: (2013)

Mitochondrial Haplogroups and Polymorphisms Reveal No Association with Sporadic Prostate Cancer in a Southern European Population
por: Álvarez-Cubero, María Jesús, et al.
Publicado: (2012)

A comprehensive study of circulating tumour cells at the moment of prostate cancer diagnosis: biological and clinical implications of EGFR, AR and SNPs
por: Puche-Sanz, Ignacio, et al.
Publicado: (2017)

Follow-Up Biomarkers in the Evolution of Prostate Cancer, Levels of S100A4 as a Detector in Plasma
por: Alvarez-Cubero, Maria Jesus, et al.
Publicado: (2022)

Genetic structure in the paternal lineages of South East Spain revealed by the analysis of 17 Y-STRs
por: Saiz, María, et al.
Publicado: (2019)

Identification of MicroRNAs as Viable Aggressiveness Biomarkers for Prostate Cancer
por: Martínez-González, Luis Javier, et al.
Publicado: (2021)

Post-Surgery Circulating Tumor Cells and AXL Overexpression as New Poor Prognostic Biomarkers in Resected Lung Adenocarcinoma
por: de Miguel-Pérez, Diego, et al.
Publicado: (2019)

Biofabrication of a Tubular Model of Human Urothelial Mucosa Using Human Wharton Jelly Mesenchymal Stromal Cells
por: Garzón, Ingrid, et al.
Publicado: (2021)

Single nucleotide polymorphisms in DNA repair genes as risk factors associated to prostate cancer progression
por: Henríquez-Hernández, Luis Alberto, et al.
Publicado: (2014)

Type 2 Diabetes-Related Variants Influence the Risk of Developing Prostate Cancer: A Population-Based Case-Control Study and Meta-Analysis
por: Sánchez-Maldonado, José Manuel, et al.
Publicado: (2022)

Polymorphisms in DNA-Repair Genes in a Cohort of Prostate Cancer Patients from Different Areas in Spain: Heterogeneity between Populations as a Confounding Factor in Association Studies
por: Henríquez-Hernández, Luis Alberto, et al.
Publicado: (2013)

GITAD 2020: quality assurance test through 20 years of experience
por: Álvarez, Juan Carlos, et al.
Publicado: (2022)

Usefulness of Microbiome for Forensic Geolocation: A Review
por: Haarkötter, Christian, et al.
Publicado: (2021)

Methodology for Y Chromosome Capture: A complete genome sequence of Y chromosome using flow cytometry, laser microdissection and magnetic streptavidin-beads
por: Alvarez-Cubero, M. J., et al.
Publicado: (2018)

Entrepreneurship and family business vitality: surviving and flourishing in the long term
por: Saiz-Álvarez, José Manuel, et al.
Publicado: (2019)

Systematic Review and Meta-Analyses of Aminopeptidases as Prognostic Biomarkers in Amyotrophic Lateral Sclerosis
por: Teruel-Peña, Bárbara, et al.
Publicado: (2023)

ISG15 as a prognostic biomarker in solitary fibrous tumour
por: Mondaza-Hernandez, Jose L., et al.
Publicado: (2022)

Determination of Exosome Mitochondrial DNA as a Biomarker of Renal Cancer Aggressiveness
por: Arance, Elena, et al.
Publicado: (2021)

MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression
por: Li, Peizhang, et al.
Publicado: (2022)

The value of lncRNA FENDRR and FOXF1 as a prognostic factor for survival of lung adenocarcinoma
por: Herrera-Merchan, Antonio, et al.
Publicado: (2017)

ExoFiT trial at the Atacama Desert (Chile): Raman detection of biomarkers by representative prototypes of the ExoMars/Raman Laser Spectrometer
por: Veneranda, Marco, et al.
Publicado: (2021)

New Prognostic Biomarkers in Patients With Traumatic Brain Injury
por: Lorente, Leonardo
Publicado: (2015)

Author Correction: ExoFiT trial at the Atacama Desert (Chile): Raman detection of biomarkers by representative prototypes of the ExoMars/Raman Laser Spectrometer
por: Veneranda, Marco, et al.
Publicado: (2021)

Biclustering of gene expression data by non-smooth non-negative matrix factorization
por: Carmona-Saez, Pedro, et al.
Publicado: (2006)

Prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: protocol for a non-inferiority clinical trial
por: Napal Lecumberri, Saturnino, et al.
Publicado: (2018)

Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
por: Martinez-Diz, Silvia, et al.
Publicado: (2023)

New Uses for the Personal Glucose Meter: Detection of Nucleic Acid Biomarkers for Prostate Cancer Screening †
por: Abardía-Serrano, Clara, et al.
Publicado: (2020)

GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists
por: Carmona-Saez, Pedro, et al.
Publicado: (2007)

Discovering semantic features in the literature: a foundation for building functional associations
por: Chagoyen, Monica, et al.
Publicado: (2006)

A literature-based similarity metric for biological processes
por: Chagoyen, Monica, et al.
Publicado: (2006)

Identification of miRNAs as Biomarkers of Cardiac Protection in Non-Genetically Modified Primary Human Cardiomyocytes Exposed to Halogenated Hypnotics in an In Vitro Model of Transfection and Ischemia/Reperfusion: A New Model in Translational Anesthesia
por: Carmona-Luque, Maria Dolores, et al.
Publicado: (2022)

A correlative biomarker study and integrative prognostic model in chemotherapy‐naïve metastatic castration‐resistant prostate cancer treated with enzalutamide
por: Fernandez‐Perez, María P., et al.
Publicado: (2022)

The effect of medical and urologic disorders on the survival of patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide
por: Serrano Domingo, Juan José, et al.
Publicado: (2021)

Aquaporins as Prognostic Biomarker in Prostate Cancer
por: Kushwaha, Prem Prakash, et al.
Publicado: (2023)

bioNMF: a versatile tool for non-negative matrix factorization in biology
por: Pascual-Montano, Alberto, et al.
Publicado: (2006)

Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock
por: Ríos-Toro, Juan-Jesús, et al.
Publicado: (2017)

SENT: semantic features in text
por: Vazquez, Miguel, et al.
Publicado: (2009)

New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma
por: Lorente, Leonardo
Publicado: (2018)

The Basic Cycles of Vocational Training: Student Satisfaction and Perceived Benefit
por: Martínez-Carmona, María José, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_097p8j857rsqim3emfabs37l1l